of metabolizing enzymes involved with glucuronidation (UGT) The authors describe the class of enzymes while simultaneously highlighting exisitng evidence and knowledge gaps of UGT pharmacogenetics and ontogeny Prasad B, Gaedigk A, Vrana M, et al Ontogeny of hepatic drug transporters as quantified by LCMS/MS proteomics Clin Pharmacol Ther 2016;100(4):362–370 This comprehensive proteomic analysis in a pediatric liver cohort describes the ontogeny pattern of hepatic uptake and efflux transporters relevant drug diposition This work describes the ontogeny pattern that can be leveraged to inform physiologically based pharmacokinetic (PBPK) models that can predict hepatic drug exposure in children and adolescents Ho RH, Kim RB Transporters and drug therapy: implications for drug disposition and disease Clin Pharmacol Ther 2005;78(3):260–277 This comprehensive review from two world experts in drug transporters describes the drug transporters relevant to current drug disposition and disease International Warfarin Pharmacogenetics Consortium, Klein TE, Altman RB, et al Estimation of the warfarin dose with clinical and pharmacogenetic data N Engl J Med 2009;360(8):753–764 This consortium describes the pharmacogenetic algorithm to improve predictions of appropriate warfarin dosing compared to trasditional fixeddose approach Scott SA, Sangkuhl K, Stein CM, et al Clinical pharmacogenetics implementation consortium guidelines for CYP2C19 genotype and clopidogrel therapy: 2013 update Clin Pharmacol Ther 2013;94(3):317–323 This consortium describes the updated evidence and guidelines for CYP2C19 genotype-based clopidogrel dosing Ramsey LB, Johnson SG, Caudle KE, et al The clinical pharmacogenetics implementation consortium guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 update Clin Pharmacol Ther 2014;96(4):423–428 This consortium describes the updated evidence and guidelines for SLCO1B1 genotype-based simvastatin dosing Van Driest SL, Webber SA Pharmacogenomics: personalizing pediatric heart transplantation Circulation 2015;131(5):503–512 This pivotal review by a well known pediatric clinical pharmacologist and pediatric transplant cardiologist highlights the current pharmacogenomic evidence related to cardiac transplantation and opportunities for future research and clinical care Birdwell KA, Decker B, Barbarino JM, et al Clinical pharmacogenetics implementation consortium (CPIC) guidelines for CYP3A5 genotype and tacrolimus dosing Clin Pharmacol Ther 2015;98(1):19–24 This consortium describes the updated evidence and guidelines for CYP3A5 genotype-based tacrolimus dosing Abdel-Rahman SM, Breitkreutz ML, Bi C, et al Design and testing of an EHR-integrated, Busulfan pharmacokinetic decision support tool for the Point-of-care clinician Front Pharmacol 2016;7:65 This inovative research describes a provider decision support tool that is utilized to precisely dose pediatric busulfan in bone marrow transplant recipients ... Pharmacogenomics: personalizing pediatric heart transplantation Circulation 2015;131(5):503–512 This pivotal review by a well known pediatric clinical pharmacologist and pediatric transplant cardiologist highlights the current... This inovative research describes a provider decision support tool that is utilized to precisely dose pediatric busulfan in bone marrow transplant recipients